acetylleucyl-leucyl-norleucinal has been researched along with Schizophrenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrow, JC; Calcaterra, NE; Hoeppner, DJ; Jaffe, AE; Maher, BJ; Wei, H | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and Schizophrenia
| Article | Year |
|---|---|
Schizophrenia-Associated hERG channel Kv11.1-3.1 Exhibits a Unique Trafficking Deficit that is Rescued Through Proteasome Inhibition for High Throughput Screening.
Topics: Bortezomib; Cell Membrane; Drug Discovery; Ether-A-Go-Go Potassium Channels; Gene Expression; HEK293 Cells; High-Throughput Screening Assays; Humans; Intracellular Space; Leupeptins; Mutation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Interaction Domains and Motifs; Protein Isoforms; Protein Transport; Schizophrenia | 2016 |